Prodotto aggiunto correttamente al carrello.

discount label
H-CSVTCG-OH
Visualizzare in 3D

Biosynth logo

H-CSVTCG-OH

Rif. 3D-PP44258

1mg
189,00 €
10mg
195,00 €
100mg
349,00 €
Consegna stimata in Stati Uniti, il Venerdì 27 Dicembre 2024

Informazioni sul prodotto

Nome:
H-CSVTCG-OH
Sinonimi:
  • NH2-Cys-Ser-Val-Thr-Cys-Gly-OH
Descrizione:

Peptide H-CSVTCG-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CSVTCG-OH include the following: Human microvascular endothelial cells adhere to thrombospondin-1 via an RGD/CSVTCG domain independent mechanism ZS Chen, J Pohl , TJ Lawley, RA Swerlick - Journal of investigative , 1996 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022202X15424303 Identification of SVTCG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor, CD36 WX Li, RJ Howard , LL Leung - Journal of Biological Chemistry, 1993 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)85403-0/abstract Structure and Function of Thrombospondins W Frazier - Trends in Glycoscience and Glycotechnology, 1992 - jstage.jst.go.jphttps://www.jstage.jst.go.jp/article/tigg1989/4/16/4_16_152/_article/-char/ja/ The localization of thrombospondin-1 (TSP-1), cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) TSP receptor, and matrix metalloproteinase-9 T Wakiyama, T Shinohara, T Shirakusa - Histology and , 2001 - hh.um.eshttps://www.hh.um.es/pdf/Vol_16/16_2/The%20localization%20of%20thrombospondin-1.pdf a Motif Shared by the Malaria Circumsporozoite Protein and Thrombospondin is Mediated Exclusively by its Glycosaminoglycan-Binding Region and Not by CSVTCG SM Gantt , P Clavijo, X Baic, J Esko - may be from any type of , 2000 - search.proquest.comhttps://search.proquest.com/openview/62ac16a7ea361a737bcf29c2fb6e2573/1.pdf?pq-origsite=gscholar&cbl=18750&diss=y#page=58 adhesion to a motif shared by the malaria circumsporozoite protein and thrombospondin is mediated by its glycosaminoglycan-binding region and not by CSVTCG SM Gantt , P Clavijo, X Bai, JD Esko, P Sinnis - Journal of Biological , 1997 - ASBMBhttps://www.jbc.org/article/S0021-9258(18)38944-0/abstract Plasmodium falciparum-infected erythrocyte adhesion to the type 3 repeat domain of thrombospondin-1 is mediated by a modified band 3 protein S Eda, J Lawler , IW Sherman - Molecular and biochemical parasitology, 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0166685199000584 A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of S Chatterjee, M Wery, P Sharma - Infection and , 1995 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/iai.63.11.4375-4381.1995 Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1 R Simantov , M Febbraio , R Crombie - The Journal of , 2001 - Am Soc Clin Investighttps://www.jci.org/articles/view/9061 Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1 P CLEZARDIN , J LAWLER , J AMIRAL - Biochemical , 1997 - portlandpress.comhttps://portlandpress.com/biochemj/article-abstract/321/3/819/34171 Heparin-and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion. N Guo, HC Krutzsch, E Negre, T Vogel - Proceedings of the , 1992 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.89.7.3040 Identification of active peptide sequences in the carboxyl-terminal cell binding domain of human thrombospondin-1. MD Kosfeld, WA Frazier - Journal of Biological Chemistry, 1992 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021925818419904 Cell attachment activity of the carboxyl-terminal domain of human thrombospondin expressed in Escherichia coli. MD Kosfeld, TV Pavlopoulos, WA Frazier - Journal of Biological Chemistry, 1991 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021925818542228 THE 1998 MOYER AWARD Characteristics of Thrombospondin-1 and Its Cysteine-Serine-Valine-Threonine-Cysteine-Glycine Receptor in Burn Wounds JJ Roth, WB Hughes, FA DeClement - Journal of Burn Care , 1998 - academic.oup.comhttps://academic.oup.com/jbcr/article-abstract/19/6/487/4757981 Localization of thrombospondin-1 and its cysteine-serine-valine-threonine-cysteine-glycine receptor in colonic anastomotic healing tissue JJ Roth, MA Buckmire, RH Rolandelli - Histology and , 1998 - hh.um.eshttps://www.hh.um.es/pdf/Vol_13/13_4/Localization%20of%20thrombospondin-l%20and%20its%20cysteine-serine-valine-threonine-cysteine-glycine%20recept.pdf Thrombospondin 1 and its specific cysteine-serine-valine-threonine-cysteine-glycine receptor in fetal wounds JJ Roth, JJ Sung, MS Granick , MP Solomon - Annals of plastic , 1999 - journals.lww.comhttps://journals.lww.com/annalsplasticsurgery/abstract/1999/05000/Thrombospondin_1_and_Its_Specific.16.aspx A CD36-binding peptide from thrombospondin-1 can stimulate resorption by osteoclasts in vitro JA Carron, SC Wagstaff, JA Gallagher - and biophysical research , 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X00925749 Cloning and characterization of angiocidin, a tumor cell binding protein for thrombospondin-1 J Zhou, VL Rothman, I Sargiannidou - Journal of cellular , 2004 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jcb.20076 Cloning and characterization of CSVTCG-specific receptor of thrombospondin-1 J Zhou - 2002 - search.proquest.comhttps://search.proquest.com/openview/4936bad0f3ba407c917959e11d28a4ba/1?pq-origsite=gscholar&cbl=18750&diss=y Thrombin-stimulated calcium mobilization is inhibited by thrombospondin via CD36 J Enenstein, K Gupta, GM Vercellotti - Experimental cell research, 1998 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0014482797938635 The Functional Significance of the CSVTCG-Specific Receptor in Breast Carcinoma Progression I Sargiannidou , G Tuszynski - 2002., 2002 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA405490 Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain. GP Tuszynski, VL Rothman, M Papale - The Journal of cell , 1993 - rupress.orghttps://rupress.org/jcb/article-abstract/120/2/513/14638 Biological activities of peptides and peptide analogues derived from common sequences present in thrombospondin, properdin, and malarial proteins. GP Tuszynski, VL Rothman, AH Deutch - The Journal of cell , 1992 - rupress.orghttps://rupress.org/jcb/article-abstract/116/1/209/14270 Stimulation of platelet activation and aggregation by a carboxyl-terminal peptide from thrombospondin binding to the integrin-associated protein receptor DJ Dorahy, RF Thorne, JV Fecondo - Journal of Biological , 1997 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)77610-8/abstract Angiocidin inhibitory peptides decrease tumor burden in a murine colon cancer model C Liebig, N Agarwal, GE Ayala , G Verstovsek - Journal of Surgical , 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022480407001163 77: Inhibition of angiocidin by two novel peptides decreases tumor burden in an orthotopic nude mouse model C Liebig, N Agarwal, G Ayala - Journal of , 2007 - journalofsurgicalresearch.comhttps://www.journalofsurgicalresearch.com/article/S0022-4804(06)00707-4/abstract Inhibition of Angiogenesis by the First Type I Repeat Peptides of Thrombospondin-1 BI Yoo, GB Jeong - Korean Journal of Physical Anthropology, 2015 - e-aba.orghttps://e-aba.org/DOIx.php?id=10.11637/kjpa.2015.28.4.223 Thrombospondins as anti-angiogenic therapeutic agents B Vailh, JJ Feige - Current pharmaceutical design, 2003 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2003/00000009/00000007/art00008 Human platelet glycoprotein IIIb binds to thrombospondin fragments bearing the C-terminal region, and/or the type I repeats (CSVTCG motif), but not to the N B Catimel, L Leung , H El Ghissasi, N Mercier - Biochemical , 1992 - portlandpress.comhttps://portlandpress.com/biochemj/article-abstract/284/1/231/37093 Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding AS Asch, S Silbiger, E Heimer, RL Nachman - Biochemical and biophysical , 1992 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0006291X9291860S INTERACTIONS OF THROMBOSPONDIN WITH CELLS A PART - Thrombospondin, 1993 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=Hanf7fhm_tsC&oi=fnd&pg=PA91&dq=(%22H-CSVTCG-OH%22+OR+%22CSVTCG%22+OR+%22NH2-Cys-Ser-Val-Thr-Cys-Gly-OH%22)+AND+peptide&ots=5QKzsRxT-P&sig=rdbLm8_Kg3vhMNQEczanw_NjVTI

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP44258 H-CSVTCG-OH

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".